<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <title>CIMG Inc. acquisition summary</title>
  <style>
    body {
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial;
      background: #f5f7fa;
      margin: 0;
      padding: 24px;
      display: flex;
      justify-content: center;
    }
    .card {
      max-width: 800px;
      width: 100%;
      background: #fff;
      border-radius: 8px;
      box-shadow: 0 6px 18px rgba(35,40,50,0.08);
      padding: 20px 24px;
      box-sizing: border-box;
    }
    table.meta {
      width: 100%;
      border-collapse: collapse;
      margin-bottom: 16px;
    }
    table.meta th, table.meta td {
      text-align: left;
      padding: 8px 6px;
      border-bottom: 1px solid #eef1f5;
      font-size: 14px;
    }
    table.meta th {
      color: #333;
      width: 140px;
      font-weight: 600;
    }
    h1 {
      font-size: 20px;
      margin: 6px 0 12px 0;
      font-weight: 700;
      color: #0b2545;
    }
    p.summary {
      margin: 0 0 12px 0;
      color: #222;
      line-height: 1.45;
      font-size: 15px;
    }
    .cols {
      display: flex;
      gap: 24px;
      flex-wrap: wrap;
      margin-bottom: 12px;
    }
    .col {
      flex: 1 1 300px;
    }
    .col h3 {
      margin: 0 0 8px 0;
      font-size: 15px;
      color: #0b2545;
    }
    ul {
      margin: 0;
      padding-left: 20px;
      color: #1b2b42;
      line-height: 1.5;
    }
    a.article-link {
      display: inline-block;
      margin-top: 12px;
      color: #0b6efd;
      word-break: break-all;
      text-decoration: none;
    }
    a.article-link:hover { text-decoration: underline; }
    .disclaimer {
      margin-top: 18px;
      color: #6b7280;
      font-size: 13px;
      font-style: italic;
    }
  </style>
</head>
<body>
  <div class="card" role="article">
    <table class="meta" aria-label="Ticker and metadata">
      <tr>
        <th>Ticker</th>
        <td>IMG</td>
      </tr>
      <tr>
        <th>Float</th>
        <td>6.7 M</td>
      </tr>
      <tr>
        <th>IO</th>
        <td>0.09%</td>
      </tr>
      <tr>
        <th>MC</th>
        <td>9.5 M</td>
      </tr>
      <tr>
        <th>Extra Info</th>
        <td>High CTB</td>
      </tr>
    </table>

    <h1><strong>CIMG Inc. Enters into Agreement to Acquire Daren Business Technology Limited, Expanding into the Biopharmaceutical Industry</strong></h1>

    <p class="summary">
      CIMG Inc. announced an agreement to acquire Daren Business Technology Limited, marking an entry into the biopharmaceutical industry. For traders: the company is a microcap (MC ~9.5M) with a small float (6.7M) and very low current IO (0.09%), while borrow costs are reported high (High CTB). The acquisition could materially change the company's business profile and volatility, but deal terms and financing details were not provided in the announcement.
    </p>

    <div class="cols">
      <div class="col">
        <h3>Positive</h3>
        <ul>
          <li>Strategic expansion into biopharma could open new revenue streams.</li>
          <li>Small float and microcap profile may amplify price moves on news.</li>
          <li>High CTB suggests borrowing shares to short may be costly.</li>
        </ul>
      </div>

      <div class="col">
        <h3>Negative</h3>
        <ul>
          <li>Very small market cap and limited liquidity increase risk and volatility.</li>
          <li>IO is low now — limited available borrow could change if short interest rises.</li>
          <li>No deal terms disclosed publicly; potential dilution or financing risk unknown.</li>
        </ul>
      </div>
    </div>

    <div>
      <a class="article-link" href="https://www.prnewswire.com/news-releases/cimg-inc-enters-into-agreement-to-acquire-daren-business-technology-limited-expanding-into-the-biopharmaceutical-industry-302683833.html" target="_blank" rel="noopener noreferrer">https://www.prnewswire.com/news-releases/cimg-inc-enters-into-agreement-to-acquire-daren-business-technology-limited-expanding-into-the-biopharmaceutical-industry-302683833.html</a>
    </div>

    <div class="disclaimer">⚠️ This summary is for informational purposes only and not trading advice. Verify details from the original source and consider consulting a licensed financial professional before making investment decisions.</div>
  </div>
</body>
</html>